Although adiponectin is generally described as a protective adipokine [16] and thought to protect podocyte function in early onset kidney disease [18, 42–44], the role of adiponectin in the later stages of human renal failure is unclear [18] with some studies suggesting that it is harmful [19, 20]. Here, ADIPOQ is linked to Renal insufficiency.